Machine signal
Active cluster sell — 9 distinct insiders, $4M, window ends Sep 17, 2026.
Figures computed from official regulatory filings — .
Analysttarget 186.76 USD (+11%) · consensus 4/5 · 10 buy · 7 hold · 1 sell
Ownershipinsiders 0.44% · institutions 108.34% · short 3.9% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for ICON PLC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, contract staffing, data solutions, and laboratory services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers testing services comprising bioanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, medical imaging, real world intelligence, site and patient, and strategic solutions. Additionally, it provides therapeutics for cardiovascular, central nervous system, endocrine and metabolic disorders, hepatology, infectious diseases, internal medicine immunology, and oncology. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
37 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Murphy Ronan Martin | Exercise | $629.3K | SEC |
| CLIMAX JOHN DR | Sell | $875.9K | Unusual size | SEC |
| CLIMAX JOHN DR | Exercise | $629.3K | SEC |
| Murphy Ronan Martin | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| McCague Eugene Pacelli | Exercise | $409.3K | SEC |
| McCague Eugene Pacelli | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| McCague Eugene Pacelli | Sell | $569.6K | Unusual size | SEC |
| CLIMAX JOHN DR | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Murphy Ronan Martin | Sell | $875.9K | Unusual size | SEC |
| Grais Linda Strack record | Sell | $97K | SEC |
| CLIMAX JOHN DR | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Clerkin Nigel Bernard John | Sell | $42.4K | SEC |
| Murray Ciaran | Sell | $45.6K | SEC |
| Clerkin Nigel Bernard John | Sell | $29.8K | SEC |
| O'Neill Julie | Sell | $17.2K | SEC |
| Grais Linda Strack record | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Whitaker Anne Clem | Exercise | n/a (No price was disclosed in the filing) | SEC |
| CLIMAX JOHN DR | Sell | $15.6K | SEC |
| McCague Eugene Pacelli | Sell | $97K | SEC |
| O'Neill Julie | Sell | $15.5K | SEC |
| Murphy Ronan Martin | Sell | $14.3K | SEC |
| Murray Ciaran | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Murphy Ronan Martin | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| McCague Eugene Pacelli | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Murray Ciaran | Sell | $35.1K | SEC |